Dianthus Therapeutics (DNTH) Free Cash Flow Growth (3y) (2020 - 2025)
Dianthus Therapeutics (DNTH) Free Cash Flow Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.07% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -56.88% |
| Jun 30, 2025 | -12.12% |
| Mar 31, 2025 | -11.84% |
| Dec 31, 2024 | -20.49% |
| Sep 30, 2024 | -11.89% |
| Jun 30, 2024 | -3.52% |
| Mar 31, 2024 | 3.73% |
| Dec 31, 2023 | 5.25% |
| Sep 30, 2023 | 11.38% |
| Jun 30, 2023 | 37.26% |
| Mar 31, 2023 | 15.03% |
| Dec 31, 2022 | 17.44% |
| Sep 30, 2022 | 49.84% |
| Jun 30, 2022 | -1.43% |
| Mar 31, 2022 | -7.14% |
| Dec 31, 2021 | -13.66% |
| Sep 30, 2021 | -4.89% |
| Jun 30, 2021 | -9.93% |
| Mar 31, 2021 | -20.09% |
| Dec 31, 2020 | -19.23% |